Triclosan-bacteria interactions: Single or multiple target sites?

Letters in Applied Microbiology

Volumn 41, Issue 6, 2005, Pages 476-481

  Gomez Escalada, M ^a   Russell, A D ^a   Maillard, J Y ^a   Ochs, D ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Ciba Grenzach GmbH   (Germany)

Author keywords

Antibacterial activity; Concentration; Growth phase; Triclosan

Indexed keywords

BACTERIA; BACTERICIDES; PHENOLS; POPULATION STATISTICS; SUSPENSIONS (FLUIDS);

ANTI-BACTERIAL ACTIVITY; BISPHENOLS; CONCENTRATION; GROWTH PHASE; GROWTH PHASIS; MICRO-ORGANISMS; MULTIPLE TARGETS; POPULATION GROWTH; TARGET SITES; TRICLOSAN;

GROWTH KINETICS;

4,4' ISOPROPYLIDENEDIPHENOL; TRICLOSAN;

ANTIMICROBIAL ACTIVITY;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERICIDAL ACTIVITY; BACTERIUM; CONCENTRATION RESPONSE; CULTURE MEDIUM; GROWTH INHIBITION; KINETICS; LETHALITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

BACTERIA (MICROORGANISMS);

EID: 28444431650     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2005.01790.x     Document Type: Article

References (26)

1. Anon. (1998) General Information on Chemical, Physical and Microbiological Properties. Grenzach-Wyhlen, Germany: Ciba Specialty Chemicals. Irgasan DP300/Irgacare MP/Irgacide LP10.
2. Bhargava, H.N. and Leonard, P.A. (1996) Triclosan: applications and safety. Am J Infect Control 24, 209-218.
3. Brady, L.M., Thomson, M., Palmer, M.A. and Harkness, J.L. (1990) Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Aus 152, 240-243.
4. CEN (Comité Européen de Normalisation, European Committee for Standardization). (1997a). EN 1276 Chemical disinfectants and antiseptics - Quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics for use in food, industrial, domestic and institutional areas - Test method and requirements (phase 2, step 1). London: British Standard Institute.
5. CEN (Comité Européen de Normalisation, European Committee for Standardization). (1997b). EN 1499 Chemical disinfectants and antiseptics - Hygienic handwash - Test method and requirements (phase 2, step 2). London: British Standard Institute.
6. Gilbert, P., Allison, D.G. and McBain, A.J. (2002) Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? J Appl Microbiol 92 (Suppl. 1), 98-110.
7. Gomez Escalada, M., Harwood, J.L., Maillard, J.-Y. and Ochs, D. (2005) Triclosan inhibition of fatty acid synthesis and its effect on growth of E. coli and Ps. aeruginosa. J Antimicrob Chemother 55, 879-882.
8. Heath, R.J., Yu, Y.-T., Shapiro, S., Olson, E. and Rock, C.O. (1998) Broad spectrum antimicrobial biocides target the FabI component of fatty acid biosynthesis. J Biol Chem 273, 30316-30320.
9. Heath, R., Rubin, J., Holland, D., Zhang, E.L., Snow, M.E. and Rock, C.O. (1999) Mechanism of triclosan inhibition of bacterial fatty acid biosynthesis. J Biol Chem 274, 11110-11114.
10. Heath, R.J., White, S.W. and Rock, C.O. (2001) Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res 40, 467-497.
11. Jones, R.D., Jampani, H.B., Newman, J.L. et al. (2000) Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 28, 184-196.
12. Langsrud, S. and Sundheim, G. (1998) Factors influencing a suspension test method for antimicrobial activity of disinfectants. J Appl Microbiol 85, 1006-1012.
13. Larkin, M. (1999) A close look at triclosan raises questions. Lancet 353, 1160.
14. Levy, C.W., Roujeinikova, A., Sedelnikova, S., Baker, P.J., Stuitje, R., Slabast, A.R., Rice, D.W. and Rafferty, J.B. (1999) Molecular basis of triclosan activity. Nature 398, 384-385.
15. McDonnell, G. and Russell, A.D. (1999) Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev 12, 147-179.
16. McMurry, L.M., Oethinger, M. and Levy, S.B. (1998a) Triclosan targets lipid synthesis. Nature 394, 531-532.
17. McMurry, L.M., Oethinger, M. and Levy, S.B. (1998b) Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 166, 305-309.
18. McMurry, L.M., McDermot, P.F. and Levy, S.B. (1999) Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 43, 711-713.
19. Regos, J. and Hitz, H.R. (1974) Investigations on the mode of action of triclosan, a broad spectrum antimicrobial agent. Zentralbl Bakteriol Hyg I Abt Orig 226, 390-401.
20. Russell, A.D. (2003) Biocide usage and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis 3, 794-803.
21. Russell, A.D. (2004) Whither triclosan? J Antimicrob Chemother 53, 693-695.
22. Suller, M.T.E. and Russell, A.D. (2000) Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 46, 11-18.
23. Villalain, J., Mateo, C.R., Aranda, F.J., Shapiro, S. and Micol, V. (2001) Membranotropic effects of the antibacterial agent triclosan. Arch Biochem Biophys 390, 128-136.
24. Walsh, S.E., Maillard, J.-Y. and Russell, A.D. (1999) ortho-Phthalaldehyde: a possible alternative to glutaraldehyde for high-level disinfection. J Appl Microbiol 86, 1039-1046.
25. Webster, J., Foagali, J.L. and Cartwright, D. (1994) Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 30, 59-64.
26. Zafar, A.B., Butler, R.C., Reese, D.J., Gaydos, L.A. and Mennonna, P.A. (1995) Use of 0.3% triclosan (Bacti-Stat*) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 23, 200-208.